Úvod Sample Clauses

Úvod. (i) INSTITUTION and INVESTIGATOR shall process Personal Data as determined in this Schedule III on behalf of ERGOMED (the Sponsor’s processor) as ERGOMED’s sub- processors. Nothing in this Agreement derogates or prevents the INSTITUTION or INVESTIGATOR to keep Clinical Trial and medical documentation as prescribed by the applicable mandatory Regulations, nor excludes their obligations and responsibilities as Controllers when they Process Personal Data of their employees, contractors, sub- contractors or Clinical Trial Subjects. (i) POSKYTOVATEL a ZKOUŠEJÍCÍ jsou povinni zpracovávat Osobní údaje podle této Přílohy č. III jménem společnosti ERGOMED (zpracovatel Zadavatele) jakožto dílčí zpracovatelé společnosti ERGOMED. Žádné ustanovení této Smlouvy nebrání nebo neomezuje POSKYTOVATELI nebo ZKOUŠEJÍCÍMU v plnění jejich povinnosti uchovávat dokumentaci Klinického hodnocení a zdravotnickou dokumentaci podle požadavků kogentních Předpisů, ani nevylučuje jejich povinnosti a odpovědnosti jakožto Správců při Zpracovávání Osobních údajů svých zaměstnanců, dodavatelů, subdodavatelů či Subjektů klinického hodnocení.
Sample 1Sample 2
AutoNDA by SimpleDocs
Úvod. The Breast International Group (BIG), Alliance Foundation Trials (AFT), Frontier Science and Technology Research Foundation (FS), Institut Xxxxx Xxxxxx (IJB) and Roche Products Limited (Roche) are conducting a clinical trial entitled “A phase III, multicentre, randomised, open-label study comparing atezolizumab (anti-PD-L1 antibody) in combination with adjuvant anthracycline/taxane-based chemotherapy versus chemotherapy alone in patients with operable triple-negative breast cancer” (the “Study”), and this document outlines the Publication and Presentation Policy for this Study. Breast International Group (BIG), Alliance Foundation Trials (AFT), Frontier Science and Technology Research Foundation (FS), Institut Xxxxx Xxxxxx (IJB) a Roche Products Limited (Roche) provádějí klinické hodnocení s názvem „Multicentrická, randomizovaná, otevřená studie fáze III porovnávající atezolizumab (protilátku proti PD-L1) v kombinaci s adjuvantní chemoterapií založenou na antracyklinu/taxanu oproti chemoterapii samotné u pacientů s operabilním trojitě negativním nádorem prsu“(xxxx xxx „Studie“) a tento dokument uvádí přehled Zásad publikace a prezentace týkající se této Studie. The key principles outlined in this document are based on the publication guidelines of the lead partners in this Study (and BIG Guidelines for Publications and Presentations), and the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts submitted to Biomedical Journals, (xxx.XXXXX.xxx). Klíčové principy uvedené v tomto dokumentu jsou založeny na pokynech k publikaci vedoucích partnerů v této Studii (Pokyny BIG pro publikace a prezentace) a jednotných požadavcích komise International Committee of Medical Journal Editors (ICMJE) týkajících se rukopisů předložených biomedicínským časopisům (xxx.XXXXX.xxx).
Sample 1
Úvod. 1.1. This securities trading agreement (hereinafter the “Agreement”) is concluded between you, the client, and us, Admiral Markets Cyprus Ltd (Registration number HE310328, CySEC License number 201/13). We refer to ourselves as ‘AM CY’, ‘we’, ‘our’, ‘us’ and ‘ourselves’ as appropriate, and the client is referred to as ‘you’, ‘your’, ‘yours’, ‘yourself’ and ‘Client’ as appropriate. AM CY may choose to amend this Agreement as per clause 20, in accordance to its sole and absolute discretion. You do not have and shall not have any right whatsoever to amend this Agreement.
Sample 1
Úvod. 1.1 Zadávateľ s radosťou víta, že Inštitúcia a Skúšajúci súhlasili s účasťou na klinickej výskumnej štúdii na báze spolupráce (ďalej ako „Štúdia“) v Inštitúcii opísanej ďalej, ktorú sponzoruje Zadávateľ. Ak má byť táto Štúdia prospešná všetkým stranám, je dôležité, aby zmluvné strany uzavreli dohodu s ohľadom na základné praktiky platné pre túto Štúdiu. V súlade s tým táto Dohoda uvádza termíny a podmienky platné pre toto výskumné úsilie na báze spolupráce.
Sample 1
Úvod. XXXXX is a new standard and new solution of CUTE presented by IATA as a CUTE successor. IATA Common Use Recommended Practice (RP) 1797 has undergone significant changes to reflect new technology. A new version of RP 1797 has been published jointly by IATA, ATA, and ACI (IATA RP1797, ATA RP30.201, and ACI RP500A07). The RP is now called XXXXX – Common Use Passenger Processing Systems – with the same number, RP 1797. XXXXX je nový standard a nové řešení CUTE, jež IATA prezentuje jako nástupce CUTE. Doporučená praxe IATA Common Use Recommended Practice (RP) 1797 prošla významnými změnami tak, aby odrážela zavedení této nové technologie. Nová verze RP 1797 byla společně publikována IATA, ATA a ACI (IATA RP1797, ATA RP30.201, a ACI RP500A07). RP se nyní nazývá XXXXX – Common Use Passenger Processing Systems – a xxxxxxx xxxxxxxxx xxxx xxxxxxx xxxxxxxx XX 0000. XXXXX is the next evolutionary step of Common- Use Terminal Equipment (CUTE), which addresses and corrects the majority of complains and deficiencies airlines perceived to be associated with the CUTE environment. XXXXX je dalším vývojovým krokem Common- Use Terminal Equipment (CUTE), který řeší a odstraňuje většinu stížností a nedostatků, které letecké společnosti vnímaly jako problém v prostředí CUTE. XXXXX is based on more open standards-based environment than CUTE and has been specifically designed to easily incorporate new technologies as they become available, as near field communications (NFC) devices. Technologie XXXXX je založena na více standardizovaném prostředí než CUTE a je určena především pro snazší začleňování nových technologií v době, kdy budou dostupné, jako jsou například zařízení s podporou near field communications (NFC). Additionally, XXXXX has well-defined technical standard, along with a third party certification processes, to ensure compatibility between different suppliers of XXXXX platforms and software. These additions address the major complains that airlines had with the CUTE environment. Technologie XXXXX má navíc dobře definovaný technický standard a také procesy pro certifikaci třetích stran, jimiž je zajištěna kompatibilita různých dodavatelů platforem a software XXXXX. Tyto dodatky řeší většinu výhrad leteckých společností, pokud jde o prostředí CUTE.
Sample 1

Related to Úvod

  • Sick Leave Separation Cash Out At the time of retirement from state service or at death, an eligible employee or the employee’s estate will receive cash for their compensable sick leave balance on a one (1) hour for four (4) hours basis. For the purposes of this Section, retirement will not include “vested out of service” employees who leave funds on deposit with the retirement system.

  • Cafeteria Plan As of the Distribution Date, Seaport Entertainment or any of its Subsidiaries shall establish or provide a cafeteria plan qualifying under Section 125 of the Code (the “Seaport Entertainment Cafeteria Plan”) allowing for the payment of welfare plan premiums on a pre-tax basis by Transferring Employees. As of January 1 of the calendar year following the calendar year in which the Distribution Date occurs, Seaport Entertainment or any of its Subsidiaries shall amend the Seaport Entertainment Cafeteria Plan to also provide for health care and dependent care flexible spending reimbursement accounts thereunder in which Transferring Employees who meet the eligibility criteria thereof may be immediately eligible to participate. From the Distribution Date until the end of the calendar year in which the Distribution Date occurs, each Transferring Employee who participated in health care or dependent care flexible spending reimbursement accounts under HHH’s cafeteria plan (the “HHH Cafeteria Plan”) immediately prior to the Effective Time will be permitted to continue participation in such flexible spending reimbursement accounts, and applicable elections and payroll deductions that were in effect immediately before the Effective Time will continue, during the Transferring Employee’s continued employment with the Seaport Entertainment Group on and after the Effective Time, with the amount of such payroll deductions transferred to HHH pursuant to the HHH Cafeteria Plan. As soon as practicable following the claim submission deadline under the HHH Cafeteria Plan for claims incurred in the calendar year in which the Distribution Date occurred, the HHH Group shall determine the aggregate accumulated contributions to the flexible spending reimbursement accounts under the HHH Cafeteria Plan made during such year by the Transferring Employees less the aggregate reimbursement payouts made for such year from such accounts to such Transferring Employees (the “Net FSA Balance”). If the Net FSA Balance is positive, the HHH Group shall pay to the Seaport Entertainment Group an amount in cash equal to the Net FSA Balance. From the Distribution Date until the end of the calendar year in which the Distribution Date occurs, HHH shall be solely responsible for all claims for reimbursement from the flexible spending reimbursement accounts incurred by the Transferring Employees during the calendar year that includes the Distribution Date and submitted to the HHH Cafeteria Plan by the Transferring Employee no later than the claim submission deadline with respect to such calendar year, whether such claims are incurred prior to, on or after the Distribution Date, which claims shall be paid pursuant to and under the terms of the HHH Cafeteria Plan.

  • SEPARATION PAY 23.01 A regular employee shall be entitled to separation pay as set out in subsection 23.03 provided he has not been excluded by subsection 23.02 and provided he meets any of the following eligibility provisions:

  • Leave Without Pay An employee shall not be entitled to payment for a public holiday falling during a period of leave without pay (including sick leave and military leave without pay) unless the employee has worked during the fortnight ending on the day on which the holiday is observed.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!